Safe duration of postoperative monitoring for malignant hyperthermia susceptible patients

被引：7

作者：

Pollock, N ^{[1
]}

Langton, E ^{[1
]}

Stowell, K ^{[1
]}

Simpson, C ^{[1
]}

McDonnell, N ^{[1
]}

机构：

[1] Palmerston N Hosp, Dept Anaesthesia & Intens Care, Palmerston North, New Zealand

来源：

ANAESTHESIA AND INTENSIVE CARE | 2004年 / 32卷 / 04期

关键词：

monitoring; postoperative; malignant hyperthermia; post-anaesthetic care unit; non-triggering anaesthesia;

D O I：

10.1177/0310057X0403200407

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Postoperative management of malignant hyperthermia (MH) susceptible patients has changed substantially over the last 20 years, with many patients now managed as day cases. Our previous policy was to monitor known MH susceptible patients (and relatives of known MH susceptible individuals not yet investigated by muscle biopsy) for four hours in the Post Anaesthetic Care Unit. However, anaesthetic literature reports suggest that MH reactions usually commence within one hour of anaesthesia. For this reason we conducted a retrospective review of Post Anaesthetic Care Unit data in 254 MH susceptible/related patients treated between 1991 and late 2000. On the basis of this review we instituted a policy change and reduced our monitoring time to one hour in the Post Anaesthetic Care Unit with a further 1.5h in a step-down unit if indicated. A prospective study in a further 68 MH susceptible/related patients showed that no MH reactions were missed due to the shorter monitoring period.

引用

页码：502 / 509

页数：8

共 50 条

[41] THE USE OF AMIDE LOCAL-ANESTHETICS IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
MINASIAN, A
YAGIELA, JA
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1988, 66 (04): : 405 - 415
[42] Malignant Hyperthermia in Canada: Characteristics of Index Anesthetics in 129 Malignant Hyperthermia Susceptible Probands
Riazi, Sheila
Larach, Marilyn Green
Hu, Charles
Wijeysundera, Duminda
Massey, Christine
Kraeva, Natalia
ANESTHESIA AND ANALGESIA, 2014, 118 (02): : 381 - 387
[43] MALIGNANT HYPERTHERMIA AFTER ORAL AND INTRAVENOUS PRETREATMENT WITH DANTROLENE IN A PATIENT SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
RUHLAND, G
HINKLE, AJ
ANESTHESIOLOGY, 1984, 60 (02) : 159 - 160
[44] MULTIPLE ANESTHETICS FOR A MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENT
LLOYD, EL
ANAESTHESIA, 1989, 44 (01) : 76 - 77
[45] USE OF ATRACURIUM IN A PATIENT SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
MICHEL, PA
FRONEFIELD, HP
ANESTHESIOLOGY, 1985, 62 (02) : 213 - 213
[46] MULTIPLE ANESTHETICS FOR A MALIGNANT HYPERTHERMIA SUSCEPTIBLE PATIENT
EMMANUEL, ER
ANAESTHESIA, 1988, 43 (08) : 666 - 670
[47] Anaesthetic considerations for a possible malignant hyperthermia susceptible
Hersch, PE
Matheson, KH
ANAESTHESIA, 1996, 51 (01) : 99 - 99
[48] DESFLURANE IS A TRIGGER OF MALIGNANT HYPERTHERMIA IN SUSCEPTIBLE SWINE
WEDEL, DJ
IAIZZO, PA
MILDE, JH
ANESTHESIOLOGY, 1991, 74 (03) : 508 - 512
[49] NEUROSURGERY IN THE MALIGNANT HYPERTHERMIA-SUSCEPTIBLE PATIENT
WACKYM, PA
DUBROW, TJ
ABDULRASOOL, IH
PEACOCK, WJ
NEUROSURGERY, 1988, 22 (06) : 1032 - 1036
[50] THE ANESTHETIC MANAGEMENT OF THE MALIGNANT HYPERTHERMIA SUSCEPTIBLE PARTURIENT
DOUGLAS, MJ
MCMORLAND, GH
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1986, 33 (03) : 371 - 378

← 1 2 3 4 5 →